Elderly patients: although consideration should be given to initiating therapy with 75 mg in patients over 75 years of age, dosage adjustment is not usually necessary for the elderly.
Selvom initialdosis på 75 mg bør overvejes til patienter > 75 år, er g det sædvanligvis ikke nødvendigt at dosisjustere ældre patienter.